Prevention of mucormycosis in COVID-19 – the need of the hour

Ish, Pranav; Ish, Somya

Read More

Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India – Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1

Sen, Mrittika………

Read More

The emergence of post-COVID-19 mucormycosis in India Can we prevent it?

Gupta, Amod; Sharma, Aman; Chakrabarti, Arunaloke

Read More

Rise of the phoenix Mucormycosis in COVID-19 times

Ravani, Swati A; Agrawal, Garima A; Leuva, Parth A; Modi, Palak H; Amin, Krisha D

Read More

Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: Clinico-radiological features

Rao, Raksha; Shetty, Adheesh P; Nagesh, Chinmay P

Read More

Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19

Honavar, Santosh G

Read More

Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis

Mohsen Bahmani Kashkouli, Parya Abdolalizadeh, Mitra Oghazian, Yasaman Hadi, Nasser Karimi, Mahya Ghazizadeh

Read More

https://bjo.bmj.com/content/103/10/1460